NTLA-2001: Clinical Trials

3 trials of NTLA-2001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2
Phase 11Completed 1

Follow NTLA-2001: new trials by email Literature Review of NTLA-2001 trials Research Report on NTLA-2001

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study of NTLA-2001 in ATTRv-PN
nexiguran ziclumeran, Normal Saline as Placebo - Neuromuscular Disease, Neuromuscular Diseases (NMD)
Phase 3RecruitingIntellia Therapeutics602024-11-222026-04-16
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
NTLA-2001, Placebo - Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Phase 3RecruitingIntellia Therapeutics12002023-12-132026-03-27
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)
NTLA-2001 - Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
Phase 1CompletedIntellia Therapeutics722020-11-052026-01-30

Conditions studied

Amyloidosis (3)  ·  Amyloid Neuropathies, Familial (2)  ·  Amyloidosis, Familial (2)  ·  Amyloidosis, Hereditary, Transthyretin-Related (2)  ·  Cardiomyopathies (2)  ·  Polyneuropathies (2)  ·  Amyloid Neuropathies (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Intellia Therapeutics (3)

Countries

Argentina (2)  ·  Brazil (2)  ·  France (2)  ·  Mexico (2)  ·  New Zealand (2)  ·  Singapore (2)  ·  Sweden (2)  ·  Taiwan (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)

Results publications

PMID 34175043, PMID 34215024, PMID 39555828, PMID 41002250